01/08/2007
ReGen Therapeutics Plc (the “Company”) is pleased to announce that its website is now fully compliant with Rule 26 of the AIM Rules for Companies, published by the London Stock Exchange plc.
The Company’s website can be viewed at the following address:-
www.regentherapeutics.com
The website also contains general information on the Company, its management, details of research and development projects and latest news on its activities.
Further information:
Andrew Marshall
Greycoat Communications
Tel: 020 7960 6007
Mobile: 07785 297111
Percy Lomax
Chairman and Chief Executive
ReGen Therapeutics Plc
Tel: 020 7153 4920
Imran Ahmad/Cecil Jordaan
HB Corporate
Tel: 0207 510 8600